Skadden Reps McKesson In $2B US Oncology Deal
McKesson Corp., the largest pharmaceuticals distributor in the U.S., said Monday that it has agreed to buy US Oncology Inc. in a $2.16 billion deal that includes the assumption of the...To view the full article, register now.
Already a subscriber? Click here to view full article